Home

Slepa vera mi Pregon cholesterol ldl hdl and cardiovascular risk surrogate markers oglaševati tesno Morje

e Overall approach to lipid-lowering therapy for prevention of... |  Download Scientific Diagram
e Overall approach to lipid-lowering therapy for prevention of... | Download Scientific Diagram

Therapeutics Initiative | [92] The limitations and potential hazards of  using surrogate markers
Therapeutics Initiative | [92] The limitations and potential hazards of using surrogate markers

Metabolites | Free Full-Text | A New Look at Novel Cardiovascular Risk  Biomarkers: The Role of Atherogenic Lipoproteins and Innovative  Antidiabetic Therapies
Metabolites | Free Full-Text | A New Look at Novel Cardiovascular Risk Biomarkers: The Role of Atherogenic Lipoproteins and Innovative Antidiabetic Therapies

HDL and cardiovascular disease - The Lancet
HDL and cardiovascular disease - The Lancet

Surrogate markers for coronary heart disease (CHD) shown divided... |  Download Table
Surrogate markers for coronary heart disease (CHD) shown divided... | Download Table

Molecules | Free Full-Text | Sex-Related Differences of the Effect of  Lipoproteins and Apolipoproteins on 10-Year Cardiovascular Disease Risk;  Insights from the ATTICA Study (2002–2012)
Molecules | Free Full-Text | Sex-Related Differences of the Effect of Lipoproteins and Apolipoproteins on 10-Year Cardiovascular Disease Risk; Insights from the ATTICA Study (2002–2012)

Log-linear association of per-unit change in LDL-C and CVD risk. Data... |  Download Scientific Diagram
Log-linear association of per-unit change in LDL-C and CVD risk. Data... | Download Scientific Diagram

PDF] Triglyceride-to-HDL cholesterol ratio in the dyslipidemic  classification of type 2 diabetes. | Semantic Scholar
PDF] Triglyceride-to-HDL cholesterol ratio in the dyslipidemic classification of type 2 diabetes. | Semantic Scholar

Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk  for Coronary Heart Disease | Arteriosclerosis, Thrombosis, and Vascular  Biology
Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease | Arteriosclerosis, Thrombosis, and Vascular Biology

HDL cholesterol concentrations and risk of atherosclerotic cardiovascular  disease – Insights from randomized clinical trials and human genetics -  ScienceDirect
HDL cholesterol concentrations and risk of atherosclerotic cardiovascular disease – Insights from randomized clinical trials and human genetics - ScienceDirect

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian  randomisation study - The Lancet
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study - The Lancet

Lifestyle Therapy Targeting Hyperinsulinemia Normalizes Hyperglycemia and Surrogate  Markers of Insulin Resistance in a Large, Free-Living Population - AJPM  Focus
Lifestyle Therapy Targeting Hyperinsulinemia Normalizes Hyperglycemia and Surrogate Markers of Insulin Resistance in a Large, Free-Living Population - AJPM Focus

Association of LDL:HDL ratio with prediabetes risk: a longitudinal  observational study based on Chinese adults | Lipids in Health and Disease  | Full Text
Association of LDL:HDL ratio with prediabetes risk: a longitudinal observational study based on Chinese adults | Lipids in Health and Disease | Full Text

LDL-Particle Number (LDL-P) | Revolution Health & Wellness
LDL-Particle Number (LDL-P) | Revolution Health & Wellness

Triglycerides and cardiovascular disease - The Lancet
Triglycerides and cardiovascular disease - The Lancet

Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict  mortality in patients with medium-to-high cardiovascular risk | American  Journal of Physiology-Gastrointestinal and Liver Physiology
Surrogate scores of advanced fibrosis in NAFLD/NASH do not predict mortality in patients with medium-to-high cardiovascular risk | American Journal of Physiology-Gastrointestinal and Liver Physiology

There is a U shaped association between non high density lipoprotein  cholesterol with overall and cardiovascular mortality in chronic kidney  disease stage 3–5 | Scientific Reports
There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3–5 | Scientific Reports

Is high-density lipoprotein a modifiable treatment target or just a  biomarker for cardiovascular disease? - Martin B Whyte, 2019
Is high-density lipoprotein a modifiable treatment target or just a biomarker for cardiovascular disease? - Martin B Whyte, 2019

Causal Inference for Genetically Determined Levels of High-Density  Lipoprotein Cholesterol and Risk of Infectious Disease | Arteriosclerosis,  Thrombosis, and Vascular Biology
Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease | Arteriosclerosis, Thrombosis, and Vascular Biology

Immunologic profile and surrogate markers of subclinical... | Download  Scientific Diagram
Immunologic profile and surrogate markers of subclinical... | Download Scientific Diagram

Triglycerides and low HDL cholesterol predict coronary heart disease risk  in patients with stable angina | Scientific Reports
Triglycerides and low HDL cholesterol predict coronary heart disease risk in patients with stable angina | Scientific Reports

Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and  Incident Cardiovascular Disease | Journal of the American College of  Cardiology
Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease | Journal of the American College of Cardiology

LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for  the ideal marker - ScienceDirect
LDL-C, NON-HDL-C and APO-B for cardiovascular risk assessment: Looking for the ideal marker - ScienceDirect

Effect of Diabetes Medications on Cardiovascular Risk and Surrogate Markers  in Patients with Type 2 Diabetes | Semantic Scholar
Effect of Diabetes Medications on Cardiovascular Risk and Surrogate Markers in Patients with Type 2 Diabetes | Semantic Scholar